Literature DB >> 25367602

Diagnostic and therapeutic advancements for aerobic vaginitis.

Cha Han1, Wenjuan Wu, Aiping Fan, Yingmei Wang, Huiying Zhang, Zanjun Chu, Chen Wang, Fengxia Xue.   

Abstract

BACKGROUND: Aerobic vaginitis (AV) is a newly defined clinical entity that is distinct from candidiasis, trichomoniasis and bacterial vaginosis (BV). Because of the poor recognition of AV, this condition can lead to treatment failures and is associated with severe complications, such as pelvic inflammatory disease, infertility, preterm birth and foetal infections.
OBJECTIVE: This review describes the diagnosis and treatment of AV and the relationship between AV and pregnancy.
RESULTS: The characteristics of AV include severely depressed levels of lactobacilli, increased levels of aerobic bacteria and an inflamed vagina. The diagnosis is made by microscopy on wet mounts of fresh vaginal fluid, and some distinct clinical features are recognized. Vaginal suppositories that contain kanamycin or clindamycin have shown curative effects in nonpregnant women. Additionally, the application of topical probiotics can restore the vaginal flora and reduce the recurrence of AV. Clindamycin vaginal suppositories and probiotics may be a better choice for gravida with AV than metronidazole. AV requires prompt attention, and the early diagnosis and treatment of AV during pregnancy significantly improves perinatal outcomes.
CONCLUSION: Further research is needed to define the pathogenesis, diagnostic criteria and standard treatment guidelines for AV.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367602     DOI: 10.1007/s00404-014-3525-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  16 in total

1.  Abnormal vaginal flora in symptomatic non-pregnant and pregnant women in a Greek hospital: a prospective study.

Authors:  G S Tansarli; T Skalidis; N J Legakis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-13       Impact factor: 3.267

2.  Selecting anti-microbial treatment of aerobic vaginitis.

Authors:  Gilbert G G Donders; Katerina Ruban; Gert Bellen
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

3.  Aerobic vaginitis in late pregnancy and outcomes of pregnancy.

Authors:  Cha Han; Huiyang Li; Lulu Han; Chen Wang; Ye Yan; Wenhui Qi; Aiping Fan; Yingmei Wang; Fengxia Xue
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-22       Impact factor: 3.267

4.  Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities.

Authors:  P Vieira-Baptista; J Lima-Silva; C Pinto; C Saldanha; J Beires; J Martinez-de-Oliveira; G Donders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-25       Impact factor: 3.267

Review 5.  The vaginal microbiota, host defence and reproductive physiology.

Authors:  Steven B Smith; Jacques Ravel
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

6.  High mannose-specific lectin Msl mediates key interactions of the vaginal Lactobacillus plantarum isolate CMPG5300.

Authors:  Shweta Malik; Mariya I Petrova; Nicole C E Imholz; Tine L A Verhoeven; Sam Noppen; Els J M Van Damme; Sandra Liekens; Jan Balzarini; Dominique Schols; Jos Vanderleyden; Sarah Lebeer
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

7.  Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products.

Authors:  Lorenzo Siroli; Francesca Patrignani; Diana I Serrazanetti; Carola Parolin; Rogers A Ñahui Palomino; Beatrice Vitali; Rosalba Lanciotti
Journal:  Front Microbiol       Date:  2017-02-07       Impact factor: 5.640

8.  The colonization with Candida species is more harmful in the second trimester of pregnancy.

Authors:  Iris Holzer; Alex Farr; Herbert Kiss; Michael Hagmann; Ljubomir Petricevic
Journal:  Arch Gynecol Obstet       Date:  2017-03-03       Impact factor: 2.344

9.  Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Piotr B Heczko; Anna Tomusiak; Paweł Adamski; Artur J Jakimiuk; Grzegorz Stefański; Aleksandra Mikołajczyk-Cichońska; Magdalena Suda-Szczurek; Magdalena Strus
Journal:  BMC Womens Health       Date:  2015-12-03       Impact factor: 2.809

Review 10.  Vaginal Microbiomes Associated With Aerobic Vaginitis and Bacterial Vaginosis.

Authors:  Evelyn Kaambo; Charlene Africa; Ramadhani Chambuso; Jo-Ann Shelley Passmore
Journal:  Front Public Health       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.